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Abstract
Purpose To investigate the non-inferiority of postopera-
tive single-dose intravenous antimicrobial prophylaxis to
multiple-dose intravenous antimicrobial prophylaxis in
terms of the incidence of surgical site infections (SSIs) in
patients undergoing elective rectal cancer surgery by a
prospective randomized study.
Methods Patients undergoing elective surgery for rectal
cancer were randomized to receive a single intravenous
injection of flomoxef (group 1) or five additional doses
(group 2) of flomoxef after the surgery. All the patients had
received preoperative oral antibiotic prophylaxis (kana-
mycin and erythromycin) after mechanical cleansing
within 24 h prior to surgery, and had received intravenous
flomoxef during surgery.
Results A total of 279 patients (including 139 patients in
group 1 and 140 in group 2) were enrolled in the study. The
incidence of SSIs was 13.7 % in group 1 and 13.6 % in
group 2 (difference [95 % confidence interval]: -0.2 %
[-0.9 to 0.7 %]).
Conclusion The incidence of SSIs was not significantly
different in patients undergoing elective rectal surgery who
were treated using a single dose of postoperative antibiotics
compared to those treated using multiple-dose antibiotics
when preoperative mechanical and chemical bowel prep-
arations were employed.
Keywords Rectal cancer  Antimicrobial
prophylaxis  Surgical site infection
Introduction
To prevent surgical site infections (SSIs) in patients
undergoing colorectal surgery, the guidelines of the Cen-
ters for Disease Control and Prevention (CDC) published in
1999 [1] recommend the administration of a brief course of
chemical preparations after mechanical bowel cleansing
and limited use of intravenous antimicrobial prophylaxis
(within 24 h of surgery). The validity of using limited-dose
(such as single-dose) intravenous antimicrobial prophylaxis
was demonstrated by a meta-analysis that included 17
randomized controlled trials [2]. However, these random-
ized controlled trials (RCTs) involved subjects undergoing
colon surgery alone or a mixture of subjects undergoing
colon and rectal surgery, with a lower percentage of those
undergoing rectal surgery (range 18.6–55.0 %). Of these
trials, only three [3–5] reported the incidence of SSIs in
patients undergoing rectal surgery. Although the results
indicated that there was no significant difference between
single-dose and multiple-dose intravenous antimicrobial
prophylaxis in terms of the reduction in the incidence of
SSIs, the number of cases in each group was too small,
ranging from only 18 to 49 cases.
In comparison to surgery for colon cancer, surgery for
rectal cancer involves more extensive procedures, such as
abdomino-perineal resection and pelvic exenteration. In
addition, lateral lymph node dissection is frequently per-
formed for cases of lower rectal cancer in Japan [6]. Ost-
omy construction, preoperative radiation and a very low
anastomosis are all associated with a prolonged duration of
surgery, greater risk of bacterial contamination and a wider
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dead space [7–10]. Previous reports from Western coun-
tries have suggested that the incidence of SSIs might differ
between colon and rectal surgery [11, 12]. Two important
reports from Japan [13, 14] demonstrated a higher inci-
dence of SSIs following rectal surgery than following colon
surgery, even after the inclusion of various types of sur-
geries in the analyses. Therefore, determining the useful-
ness of short-term intravenous antimicrobial prophylaxis
specifically for reducing the incidence of SSIs in patients
undergoing rectal surgery would be of interest.
We carried out a prospective randomized non-inferiority
trial to evaluate the usefulness of short-term intravenous
antimicrobial prophylaxis combined with preoperative
chemical preparation (administration of an antibiotic(s)), in
terms of its efficacy for reducing the incidence of SSIs, and
to identify the risk factors for SSIs in patients undergoing
elective rectal cancer surgery in Japan.
Patients and methods
This study was conducted with the approval of the ethics
committee of Saitama Medical Center, Saitama Medical
University. Written informed consent was obtained from
each patient.
Patients
A total of 295 patients underwent elective resectional
surgery for rectal cancer, including rectosigmoid cancer, at
our institution between January 2003 and September 2011.
Preoperative and intraoperative procedures related
to the development of SSIs
All of the patients were given kanamycin (3 g/day) and
erythromycin (2.4 g/day) orally in three divided doses after
mechanical bowel cleansing, within 24 h prior to surgery,
in accordance with the CDC guidelines [1]. The mechan-
ical bowel preparation consisted of bowel lavage with 2 L
of polyethylene glycol or 34 g of magnesium citrate.
Thereafter, 1 g of flomoxef (FMOX), a second-generation
cephalosporin, was administered by intravenous injection,
with an additional dose administered when the duration of
surgery exceeded 3 h.
The surgical wounds were covered with surgical towels. A
stapled anastomosis was routinely performed for anterior
resections. The stump of the Hartmann’s pouch was also
closed with a stapler. A hand-sewn anastomosis was made for
intersphincteric resections. Irrespective of the type of surgery
performed, the abdominal cavity was washed with copious
amounts (2–3 L) of saline before closure of the wounds, and a
closed-suction drain (BLAKE silicone drains, Ethicon,
Johnson & Johnson, Somerville, NJ, USA) was placed pre-
sacrally, brought out through a separate stab wound, and
connected to a J-VAC suction reservoir (Ethicon, Johnson &
Johnson, Somerville, NJ, USA). All gloves were changed after
the abdominal cavity was washed. After the fascia was
approximated with absorbable sutures, the incisional site of
the abdominal wall was washed with 200 mL of saline before
closure of the skin, which was approximated with a skin sta-
pler. The perineal skin was approximated with 2-0 non-
absorbable sutures when abodomino-perineal resection or
pelvic exenteration was performed.
Randomization of the patients
After surgery, the patients were assigned to one of the
following two groups using sealed envelopes containing
randomized sheets. The patients in group 1 were given only
single-dose intravenous antimicrobial prophylaxis 1 h after
completion of the surgery, while the patients in group 2
were given an additional 5 doses over 2 consecutive days.
Patients less than 20-year old, those with a known allergy
to FMOX and those with any infection diagnosed within
the previous 2 weeks, were excluded from this study.
Postoperative follow-up
The incision site was covered with a sterile dressing, which
was removed within 48 h of surgery. In principle, the pelvic
drain was removed within 5 days of surgery, and the staples
were removed on postoperative day 7. The wounds were
inspected daily until the patients were discharged from the
hospital, and each patient’s wounds were inspected at the
outpatient clinic 30 days after surgery. SSIs (incision site
infections and organ/space infections) were recorded
according to the definitions of the CDC [1]; however, no
distinction was made between superficial and deep SSIs,
because discrimination between the two was often difficult.
Anastomotic dehiscence, which was classified into organ/
space infection, was confirmed by clinical and/or radio-
graphic examinations. Remote infection was defined as an
infection that occurred at a site other than the surgical site,
such as pneumonia, enteritis, urinary tract infection or
bloodstream (catheter-related) infection. The distribution of
the location of the primary tumor and level of lymph node
dissection was determined according to the guidelines of the
Japanese Society for Cancer of the Rectum and Anus [15],
and the distribution of the pathological stage was deter-
mined according to the TNM classification [16].
Sample size calculation
This trial was designed as a non-inferiority test to detect a
10 % difference in the incidence of SSIs between the two
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groups with a confidence interval (CI) of 95 % and sta-
tistical power of 80 %, assuming that the incidence of SSIs
in the multiple-dose intravenous antimicrobial prophylaxis
group (group 2) would be 12 %, based on the our previous
data on the incidence of SSIs after rectal cancer surgery
performed between September 2000 and September 2001.
Based on the above, it was calculated that a sample size of
131 would be required in each treatment arm. Then, the
required number of patients was set at 140 per group,
assuming a 10 % potential dropout rate. [17].
Statistical analysis
The results in the single-dose prophylaxis group (group 1)
were considered not to be inferior to those in the multiple-
dose prophylaxis (group 2) if the lower limit of the two-
sided 95 % CI for the difference in the incidence of SSIs
was above -10 %. The data are expressed as medians and
ranges or 95 % CI. For the statistical analyses, a statistical
software package (StatView ver. 5.0, Abacus Concepts,
Inc, Berkeley, CA, USA) running on a Windows personal
computer was used. For the comparison of nominal vari-
ables, either the Chi-Square test or Fisher’s exact proba-
bility test was used. For the comparison of continuous
variables, Mann–Whitney’s U test was used. P values of
\0.05 were considered to denote statistical significance.
Results
Eligible patients
A flow chart of the randomization of the patients is shown
in Fig. 1. Among the 295 patients who underwent elective
surgery for rectal cancer during the specified period, a total
of 16 patients were excluded, owing to refusal to partici-
pate in the study (two patients), inappropriate bowel
preparation and/or fecal contamination in the surgical field
(11 patients), or protocol violation with respect to the
duration of antimicrobial prophylaxis after randomization
(three patients, including two from group 1 and one from
group 2). Thus, a total of 279 patients (n = 139 for group 1
and n = 140 for group 2) were finally enrolled in the study.
Patient characteristics
The two groups did not differ significantly with respect to
the sex ratio, age, ASA (American Society of Anesthesi-
ologists physical status) score, BMI (body mass index),
prevalence of diabetes mellitus, distribution of the location
of the primary tumor, type of surgery, frequency of stoma
creation, frequency of lateral lymph node dissection, fre-
quency of combined resection of other organ(s), curative
intent of surgery, duration of surgery, blood loss, level of
lymph node dissection or distribution of the pathological
stage (Table 1).
SSIs
The incidence of incision site infections was 5.0 % (seven
patients) in group 1 and 7.1 % (10 patients) in group 2. All
the incision site infections were considered to be superficial
incision site infections. The incidence of organ/space
infections was 10.8 % (15 patients) in group 1 and 8.6 %
(12 patients) in group 2. Of the 27 organ/space infections,
12 (five in group 1 and seven in group 2) were related to
anastomotic dehiscence. Three patients in group 1 and
three patients in group 2 developed both incision site and
organ/space infections. Therefore, the overall incidence of
SSIs was 13.7 % (19 patients) in group 1 and 13.6 % (19
patients) in group 2. The difference [95 % CI] in the
incidence of SSIs between the two groups was -0.2 %
[-0.9 to 0.7 %]. Because the lower limit of the two-sided
95 % CI was above -10 %, the outcome in terms of the
incidence of SSI in group 1 was considered to be non-
inferior to that in group 2 (Table 2).
Subset analysis for SSIs
A subset analysis was performed based on the types of
surgery, namely, surgeries associated with a wide pelvic
dead space (abdomino-pelvic resection and pelvic exen-
teration) vs. other surgeries, including anterior resection,
intersphincteric resection, and Hartmann’s procedure. In
terms of the surgeries with a wide pelvic dead space, the
overall incidence of SSIs (40.0 vs. 30.0 %, P = 0.51),
incision site infections (5.0 vs. 20.0 %, P = 0.15) and
organ/space infections (35.0 vs. 15.0 %, P = 0.14) did not
differ significantly between group 1 and group 2. In terms
of the surgeries, including anterior resection, intersphinc-
teric resection and Hartmann’s procedure, the overall
incidence of SSIs (9.2 vs. 10.8 %, P = 0.68), incision site
infections (5.0 vs. 5.0 %, P [ 0.99) and organ/space
infections (6.7 vs. 7.5 %, P = 0.82) also did not signifi-
cantly among between the groups (Table 3).
Remote infections
A remote infection was detected in nine (6.5 %) and 15
patients (10.7 %) in groups 1 and 2, respectively; there was
no significant difference in the incidence of remote infec-
tion between the groups (P = 0.21) (Table 4). Among the
patients who developed enterocolitis, Clostridium difficile
toxin A was detected in one patient from Group 1. This
patient was treated with vancomycin and recovered without
further complications.
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Discussion
This study clearly showed that, in patients administered a
brief course of a chemical preparation after mechanical
bowel cleansing prior to rectal cancer surgery, postopera-
tive single-dose intravenous antimicrobial prophylaxis was
non-inferior to multiple-dose prophylaxis in terms of the
subsequent incidence of SSIs. Importantly, it appears that,
irrespective of the type of rectal cancer surgery performed,
selection between postoperative single-dose and multiple-
dose intravenous antimicrobial prophylaxis in the imme-
diate postoperative period may have little impact on the
risk of the development of SSIs.
Even though this study was performed at a single
institution, we believe that it had several distinct merits that
enhanced its quality. For example, there were no inter-
hospital variations, and the surgical procedures and pre-,
intra- and postoperative management protocols related to
SSIs were well standardized. To the best of our knowledge,
this is the first randomized study comparing postoperative
single-dose vs. multiple-dose intravenous antimicrobial
prophylaxis following a course of oral antibiotics and
mechanical bowel preparation prior to elective rectal can-
cer surgery, while Suzuki et al. [18] and our own group
[19] have previously reported the non-inferiority of single-
dose to multiple-dose intravenous antimicrobial prophy-
laxis in elective colon cancer surgery performed after
preoperative chemical and mechanical preparation.
The National Nosocomial Infections Surveillance
(NNIS) system categorizes all colorectal surgeries into the
same ‘‘COLO’’ group, and the incidence of SSIs within this
group is stratified according to the NNIS risk index
calculated based on the following three factors: the ASA
score, wound classification and duration of operation (with
3 h set as the cut-off point) [20]. The NNIS risk index has
been criticized as being unsuitable for risk evaluation in
patients undergoing elective colorectal surgery, because
most patients undergoing colorectal surgery have an ASA
score of 1 or 2 and a clean-contaminated wound [10, 21,
22]. In terms of the incidence of incisional site infections, a
retrospective analysis by Konishi et al. [13] demonstrated
that the incidence in patients undergoing elective rectal
surgery was 18.0 %, nearly twice as high as the incidence
of 9.4 % in patients undergoing elective colon surgery,
although they did not evaluate organ/space infections. The
Japanese Nosocomial Infection Surveillance (JNIS) system
analyzed the incidence of SSIs after elective and emer-
gency colon surgery and rectal surgery separately in 2009,
and reported that the incidence of SSIs was 12.7 % after
colon surgery and 16.3 % after rectal surgery [23]. It was
therefore unclear whether the same perioperative man-
agement strategies, including the duration of intravenous
antimicrobial prophylaxis, would be useful for both rectal
and colon surgery.
In our present study, none of the patients had received
preoperative chemoradiotherapy. In Western countries,
chemoradiation prior to surgery is a standard treatment for
locally advanced rectal cancer [24]. In Japan, surgery
without neoadjuvant treatment, occasionally with lateral
lymph node dissection, is the standard treatment for lower
rectal cancer [6], even though (chemo) radiation for both
upper and lower rectal cancers is performed in some
institutions. A large randomized controlled study compar-
ing total mesorectal excision (TME) with and without
Fig. 1 A flow-chart of the
randomization of the patients
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preoperative radiation for rectal cancer demonstrated the
absence of any significant difference in the overall inci-
dence of SSIs between the two groups [25]. Notably,
according to some previous studies, TME, including both
low anterior resection and abdomino-perineal resection,
was associated with a high incidence of SSIs of 27.7 and
31.6 % for the two aforementioned procedures, respec-
tively [21], even in the absence of preoperative radiation.
Nevertheless, a short course of intravenous antimicrobial
prophylaxis in patients receiving preoperative radiation
deserves investigation in the future.
There were two important randomized trials [26, 27]
from Japan that have compared the risks of SSIs following
single-dose intravenous antimicrobial prophylaxis [26] and
preoperative chemical preparation [27] in patients under-
going elective colorectal surgery. Fujita et al. [26] reported
that single-dose intravenous prophylaxis was associated
with a [3-fold increase in the overall incidence of SSIs
(14.3 vs. 4.3 %) compared to triple-dose intravenous anti-
microbial prophylaxis in patients undergoing elective
colorectal cancer surgery who had undergone mechanical
cleansing, but not chemical preparation, preoperatively.
Table 1 Patient characteristics
a Median (range)
b American Society of
Anesthesiologists physical
status
c According to the 7th TNM
Classification
d According to the Japaneses
Classification of Colorectal
Carcinoma
Group 1 (n = 139) Group 2 (n = 140) P value
Sex (male:female) 88:51 92:48 0.18
Age (years) a 65 (35–90) 65 (33–91) 0.81
ASAb score (I/II:III) 127:12 125:15 0.56
BMI (body mass index)a (kg/m2) 22.0 (15.6–32.0) 22.4 (13.2–33.0) 0.57
Diabetes mellitus (present:absent) 16:123 15:125 0.83
Location of the primary tumor 0.18
Rectosigmoid 46 38
Upper rectum 33 47
Lower rectum 60 55
Type of surgery 0.99
Hartmann’s procedure 4 5
Anterior resection 110 109
Intersphincteric resection (ISR) 5 6
Abdomino-perineal resection 18 19
Pelvic exenteration 2 1
Total pelvic exenteration 1 1
Posterior (anterior) pelvic exenteration 1 1
Stoma creation (%) 44 (31.7%) 47 (33.6%) 0.73
Colostomy (%) 25 (18.0%) 24 (17.1%)
Ileosomy (%) 19 (13.7%) 23 (16.4%)
Lateral lymph node dissection performed (%) 39 (28.1%) 30 (21.4%) 0.20
Combined resection of other organ(s) 19 (13.7%) 31 (22.9%) 0.07
Liver 4 8
Small intestine or colon 1 2
Urinary bladder 4 6
Others 11 17
Curative intent of surgeryc 0.12
R0 120 129
R1/R2 19 11
Duration of surgery (min)a 187 (83–670) 185 (80–495) 0.75
Blood loss (g)a 260 (10–5850) 310 (10–3120) 0.39





Stage 0/I/II 65 79
Stage III/IV 74 61
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They did not analyze the results separately in patients
undergoing colon cancer surgery and rectal cancer surgery.
Kobayashi et al. [27] reported that, in patients administered
intravenous antimicrobial prophylaxis until postoperative
day 3, the use of the chemical preparation was not asso-
ciated with a reduction in the overall incidence of SSIs;
however, in a subset analysis, the use of the chemical
preparation was associated with a significantly reduced
incidence of SSIs in patients undergoing abdomino-peri-
neal resection (58.8 vs. 11.1 %). This result was not con-
sistent with our results demonstrating no significant
differences in the incidence of SSIs after abdomino-peri-
neal resection/pelvic exenteration between patients
receiving single-dose and those receiving multiple-dose
intravenous antimicrobial prophylaxis postoperatively
(P = 0.74). These findings suggest that the risk of SSIs
after abdomino-perineal resection might be influenced by
the choice of chemical preparation and/or the duration of
intravenous antimicrobial prophylaxis.
It has been reported that preoperative oral antibiotic use
can induce Clostridium difficile-related colitis [28]. In our
study, we detected Clostridium difficile toxin A in only one
patient, who recovered with only conservative therapy.
Because we did not conduct routine testing for Clostridium
difficile, the exact incidence of ‘‘subclinical’’ Clostridium
difficile-related infection in our patients remains unknown.
Further studies are warranted to clarify this issue; however,
a recent retrospective multicenter study demonstrated that
chemical preparation did not increase the risk of Clos-
tridium difficile infection in patients undergoing elective
colon surgery [29].
In summary, our results suggest that the incidence of SSIs
in patients undergoing elective rectal surgery following sin-
gle-dose postoperative use of antibiotics was not significantly
different from that of those undergoing multiple-dose treat-
ments as long as preoperative mechanical and chemical
bowel preparations were employed. Therefore, the adminis-
tration of a single-dose of postoperative antibiotics is a valid
measure to prevent postoperative surgical site infections.
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